Kesios Therapeutics
Series AKesios Therapeutics raised €27M in a Series A round in Dec 2015. The company is based in London, UK. Investors in the round: Abingworth LLP, Imperial Innovations Limited, SV Life Sciences. Data as of 4 Nov 2026.
Amount raised
€27M
€26,958,002
Native amount
19,000,000 GBP
Stage
Series A
series a
Investors
3
Provenance & confidence
UnverifiedAmount
19,000,000 GBP
ECB-at-date → €27M · rate 0.7048 on 2015-11-30
High confidence
Source
No source on record — unverified.
Unverified
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
3 namedDate
Dec 2015
Round type
series a
Amount (EUR)
€27M
Other rounds
same companyThis is the company's only recorded round.